Rhön appoints new management Board members: a key role for the Central Hessian University hospital

The Rhön-Klinikum AG has set itself ambitious targets: by competitor Asklepios acquired hospital group wants to move on "concepts for a future-oriented health

Rhön appoints new management Board members: a key role for the Central Hessian University hospital

The Rhön-Klinikum AG has set itself ambitious targets: by competitor Asklepios acquired hospital group wants to move on "concepts for a future-oriented health care with vigour and new ways to walk in the forefront of medicine in Germany". As the Rhön AG tells more, is to take the Uni-Klinikum Giessen and Marburg a "key role". Details are, however. The two locations of the distributed setup in this country is the only privatized University hospital and according to the information provided by the parent company, the third largest of its kind.

Rhön has appointed two new Board members. One of the two members of the management Board, Christian Höftberger, knows the Uni-Klinikum Giessen and Marburg, from my own experience. The June 2017 as the regional managing Director of Asklepios Kliniken GmbH & co. KGaA for the Federal state of Hessen employed a lawyer, worked a few years ago as commercial Director at the University hospital in Gießen. He is currently signed as President of the Hessian hospital society, and to officiate until 2023.

New in the Executive Board of the economist should move Stefan Stranz. He currently manages the operations of the Asklepios clinics in Hamburg. The Supervisory Board has to agree to his change yet, as it is called. Höftberger and Stranz to sit from September in the Rhön-the Board of management.

in 2006, from the state of Hesse

sold Marburger, researchers from hospital and school are least due to the development of a vaccine candidate against the Coronavirus, and a low-cost ventilator came into the picture. In addition, the house operates a Corona App to help citizens and Doctors. The Covid-Online-called offer to help with a kind of questionnaire, the risk of infection to estimate the Overloading of the clinic to avoid. At the Marburg site of the Land of Hessen, formerly as a "lighthouse project" vaunted particle therapy facility for the treatment of certain types of cancer is located.

In the spring of 2006, it was sold to the short-UKGM-called big hospital of Hesse, the Rhön-group, wherein the country has retained a minority stake of five per cent. The Background is a backlog of Investment at the site in Giessen, the country was not able to dissolve formed. The Rhön-AG left soon after the Takeover, a new pull up. Nevertheless, eyeing the SPD and the Left as opposition factions in the Hessian Parliament the privatization as critical. From the employees and the works Council has been sued in the past, often about the high work load.

Updated Date: 12 August 2020, 04:20

You need to login to comment.

Please register or login.

RELATED NEWS